Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orsan Medical Technologies was an Israeli medical device company focused on noninvasive brain monitoring, especially intracranial pressure (ICP) and cerebral perfusion assessment. Its core technology used impedance plethysmography to measure cerebral volume and blood-flow-related changes across the cardiac cycle and derive hemodynamic parameters such as ICP, cerebral perfusion, autoregulation, compliance, and edema-related changes. The company’s lead product, nICP, was described as a continuous, real-time, noninvasive ICP monitor intended to help clinicians detect ICP elevation and support treatment decisions in neurocritical care. Available sources indicate the company was founded in 2006 in Netanya, Israel and is now inactive/deadpooled. It appears to have operated as a private health-tech/medical device company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orsan Medical Technologies.